Abbott Laboratories is rebounding from last year’s manufacturing shutdown of its U.S. baby formula plant thanks to strong medical device sales taking the place of lost revenue of COVID-19 tests.
Abbott Is Bouncing Back From Baby Formula Problems And Lost Covid Test Sales
